The Latest Breaking News from Cancer

‘Tremendous uncertainty’ for cancer research as US officials target mRNA vaccines

Amid Trump cuts and state-level backlash, experts worry that progress in messenger RNA vaccines could stall

The Guardian - US · Jul 12, 2025

Dave Ramsey Was Stunned When A Caller Criticized His Cancer-Stricken Wife For Not Picking Up A Side Hustle—'But She Is Stable'

Dave Ramsey has heard it all over the years, but one recent call on “The Ramsey Show” caught him completely off guard. What started as a routine budgeting question turned into a tense exchange that left both Ramsey and co-host George Kamel visibly shaken.

Benzinga · Jul 12, 2025

James Carter Cathcart, Beloved Pokémon Voice Actor, Dies at 71 — His Iconic Characters Live On

Pokémon voice actor James Carter Cathcart has died aged 71 after a battle with throat cancer. Best known for voicing Team Rocket's James, Meowth and Professor Oak, his work defined the English-language anime for millions of fans.

International Business Times UK · Jul 11, 2025

Noel Gallagher to donate large sum of Oasis Live '25 Tour earnings to charity

Noel Gallagher is said to be planning to give a good chunk of his earnings from the Oasis comeback tour to Teenage Cancer Trust.

BANG Premier · Jul 11, 2025

The Role of Flow Cytometry in Cancer Research

Flow cytometry is a cornerstone technology in modern cancer research—offering single-cell resolution, rapid multiparametric analysis, and robust data quality

inkl · Jul 11, 2025

Details of Julian McMahon’s cancer revealed a week after his death aged 56

Charmed, Fantastic Four and Nip/Tuck actor’s cause of death was lung metastasis due to head and neck cancer

The Guardian - AU · Jul 11, 2025

Julian McMahon's cause of death revealed

Charmed actor Julian McMahon passed away from lung metastasis as a result of head and neck metastatic cancer, documents have revealed.

BANG Premier · Jul 10, 2025

Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study

Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (OTC:ALPMF) (OTC:ALPMY) on Thursday released topline results from the overall survival (OS) analysis from the Phase 3 EMBARK study evaluating Xtandi (enzalutamide), in combination with leuprolide and as a monotherapy, in men with non-metastatic hormone-sensitive prostate cancer with biochemical recurrence (BCR) at high…

Benzinga · Jul 10, 2025

Kate Beckinsale posts emotional video at mom’s bedside after commenting on ‘deeply painful’ time

The actor revealed in July 2024 that her mother had stage 4 cancer

The Independent UK · Jul 10, 2025

Mapped: The best and worst performing NHS trusts in England

Trusts have been ranked by seven measures of performance on a new online dashboard

The Independent UK · Jul 10, 2025